Sands Capital

Venture Capital Active London, United Kingdom Est. 1992
LinkedIn
Last updated 2026-06-18
Portfolio
4
in our dataset
Rounds participated
6
Rounds led
1
Rounds' value
$856.0M
total disclosed, rounds participated
Stages
B Round, A Round

About

Sands Capital Ventures is a venture capital and growth equity firm that invests in innovative businesses across various sectors, including artificial intelligence, cybersecurity, healthcare technology, and fintech. Founded in 1992 and headquartered in Arlington, Virginia, the firm manages over $54 billion in assets and focuses on investments ranging from $10 million to $15 million per company.

Portfolio · 4

Snyk
Developer Security Platform
2 rounds $726.5M committed Latest: 2022-12
Prilenia Therapeutics
Developing New Treatments for Neurodegenerative Diseases
2 rounds $54.0M committed Latest: 2022-04
Nucleix
Noninvasive Testing for Early Detection of Cancer
Led ★ 1 round $22.0M committed Latest: 2022-01
SafeBreach
Breach and Attack Simulation
1 round $53.5M committed Latest: 2021-11

Investment activity

Portfolio by sector

Cyber Security2
Health Tech & Life Sciences2

Funds · 1

  • Life Sciences Pulse Fund III — $555M May 2024

Q&A

What is Sands Capital's primary investment focus?
Sands Capital Ventures invests in innovative businesses across various sectors, including artificial intelligence, cybersecurity, healthcare technology, and fintech.
When was Sands Capital founded and where is it headquartered?
Sands Capital was founded in 1992 and is headquartered in Arlington, Virginia, though its listed HQ in startupim is London, UK.
What is Sands Capital's typical investment check size?
Sands Capital focuses on investments ranging from $10 million to $15 million per company.
Which notable funds has Sands Capital raised recently?
In May 2024, Sands Capital announced the close of its Life Sciences Pulse Fund III, raising $555 million.
Can you name some of Sands Capital's portfolio companies?
Sands Capital's portfolio includes Nucleix, which focuses on noninvasive testing for early cancer detection, and SafeBreach, a breach and attack simulation platform.
What are Sands Capital's most active investment sectors?
Sands Capital shows concentration in Cyber Security and Health Tech & Life Sciences, with two portfolio companies in each sector.
What is the total amount raised by portfolio company Snyk?
Snyk, a developer security platform in Sands Capital's portfolio, has raised $1.58 billion through its G Round.
What is the total amount raised by portfolio company Prilenia Therapeutics?
Prilenia Therapeutics, which develops treatments for neurodegenerative diseases, has raised $144.5 million through its B Round.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)